Oral Poster Presentation

21 OCTOBER 2020

13.15 - 13.45 E-POSTER PRESENTATIONS SESION I - CHAIR: Volkan Karakus, Mahmut Töbü
PP 01 HYPERCALCEMIA DUE TO THE INTERACTION BETWEEN ALL TRANS RETINOIC ACID AND POSACONAZOLE USED FOR ACUTE PROMYELOCYTIC LEUKEMIA TREATMENT Senem Maral
PP 02 ACUTE CEREBELLAR SYNDROME AFTER HIGH DOSE CYTOSINE ARABINOSIDE TREATMENT: CASE REPORT Fatma Yılmaz
PP 03 AN UNUSUAL CASE REPORT: MYELOİD SARCOMA PRESENTED WITH APPENDICITIS Fatma Yılmaz
PP 04 POSTDURAL PUNCTURE SUPERIOR SAGITTAL SINUS THROMBOSIS DURING REMISSION INDUCTION THERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA Fehmi Hindilerden
PP 05 RETROSPECTIVE ANALYSIS OF ALL PATIENTS SINGLE CENTER EXPERIENCE Engin Kelkitli
PP 06 CASE REPORT: ACUTE LYMPHOBLASTIC LEUKEMIA WITH BONE INVOLVEMENT Filiz Yavaşoğlu
19.40 -20.10 ORAL PRESENTATION SESSION I - CHAIRS: Atilla Özkan, Anil Tombak
OP 09 CAN SARCOPENIA BE A RISK FACTOR FOR BLEOMYCIN TOXICITY? M. Koyuncu
OP 07 REAL EXPERIENCE OF BRENTUXIMAB VEDOTIN FOR CUTANEOUS T CELL LYMPHOMAS F. Keklik Karadag
OP 08 THE PROGNOSTIC IMPACT OF COMORBIDITY, NUTRITIONAL AND PERFORMANCE STATUS ON PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA Buğra Sağlam
OP 10 BENDAMUSTINE-BORTEZOMIB-DEXAMETHASONE (BVD) IN HEAVILY PRETREATED MULTIPLE MYELOMA: OLD/NEW IN NOVEL AGENTS' ERA Claudio Cerchione
OP 11 EFFICACY AND SAFETY OF DARATUMUMAB WITH DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND SEVERE RENAL IMPAIRMENT: RESULTS OF THE PHASE 2 DARE STUDY Evangelos Tepos
OP 13 PERIPHERAL BLOOD IMMUNE PROFILING OF MULTIPLE MYELOMA PATIENTS AT DIAGNOSIS; CORRELATIONS WITH CIRCULATING PLASMA CELLS Konstantinos Papadimitriou
19.40 -20.50 E-POSTER PRESENTATIONS SESION II - CHAIRS: Oktay Bilgir, Sebnem Izmir Guner
PP 07 CHRONIC LYMPHOCYTIC LEUKEMIA PRESENTING AS PULMONARY INVOLVEMENT IN AN ELDERLY PATIENT: A CASE REPORT Ömer Ekinci
PP 08 FREQUENCY OF BRUCELLOSIS AND HEPATITIS B VIRUS SEROPOSITIVITY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA Ömer Ekinci
PP 09 EPIDEMIOLOGICAL SPECTRUM AND DIAGNOSIS PATTERNS OF HEMATOLOGICAL MALIGNANCIES IN THE REPUBLIC OF MOLDOVA Vasile Musteata
PP 10 A RARE CASE: COEXISTENCE OF SMALL CELL LUNG CANCER AND CHRONIC LYMPHOCYTIC LEUKEMIA Merih Reis Aras
PP 11 STEVENS-JOHNSON SYNDROME SECONDARY TO RITUXIMAB ADMINISTRATION IN A CHRONIC LYMPHOCYTIC LEUKEMIA PATIENT Victor Tomacinschii
PP 12 CONCOMITANT ESSENTIAL THROMBOCYTHEMIA AND MATURE B -LYMPHOPROLIFERATIVE DISORDER IN A PATIENT Ayesha Butt
PP 14 POLYCYTHEMIA VERA: UPDATES IN DIAGNOSIS AND TREATMENT OUTCOMES Larisa Musteata
PP 15 DISEASE AND CLINICAL CHARACTERISTICS OF PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS: 11-YEAR SINGLE CENTER EXPERIENCE Pınar Cömert
PP 16 THE FREQUENCY OF CALRETICULIN AND MPL GENE MUTATIONS IN BCR-ABL AND JAK2 UNMUTATED CHRONIC MYELOPROLIFERATIVE NEOPLASMS AND ITS EFFECT ON THE OUTCOME. Tarık Onur Tiryaki
PP 17 STUDY OF JAK2V617F GENE ALLELE BURDEN IN POLYCYTHEMIA VERA. Fidan Khalilova
PP 18 CLINICAL AND ANAMNESTIC SIGNS OF HYPERCOAGULATION IN PATIENTS WITH β-THALASSEMIA Nargiz Alieva

22 OCTOBER 2020

13.20 - 13.50 E-POSTER PRESENTATIONS SESION III - CHAIRS: Ahmet Öztürk, Emin Kaya
PP 19 FACTOR XIII DEFICIENCY CASE WITH POSTTRAVMATIC SUBCUTANEOUS BLEEDING Merih Reis Aras
PP 20 ACUTE ISCHEMIC STROKE PRESENTATION OF OTHERWISE ASYMPTOMATIC COVID-19 PATIENT Elif Aksoy
PP 21 ISOLATED PRIMARY SPINAL MUCOSA-ASSOCIATED LYMPHOID TISSUE (MALT) LYMPHOMA: A RARE CASE REPORT Ömer Ekinci
PP 22 IR2 LEADING TO COMPLETE REMISSION IN R/R RICHTER SYNDROME – A CASE REPORT Emin Abdullayev
PP 23 PRIMARY SPINAL EXTRAMEDULLARY DIFFUSE LARGE B-CELL LYMPHOMA PRESENTING WITH INITIAL SPINAL CORD COMPRESSION: A CASE REPORT Ömer Ekinci
PP 24 COMPARISON OF 68GA-PSMA AND 18F-FDG PET/CT UPTAKE IN DIFFERENT LYMPHOMA Carmino De Souza
19.35 - 20.35 ORAL PRESENTATION SESSION II - CHAIRS: Duzgun Ozatli, Hilmi Dogu
OP 02 BLINATUMOMAB THERAPY IN A RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA WITH ISOLATED RADIUS INVOLVEMENT FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANT: A CASE REPORT İbrahim Halil Açar
OP 03 CARDIOVASCULAR RISK REDUCTION IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH THE TYROSINE KINASE INHIBITORS Nataliia Lopina
OP 04 ANALYSIS OF DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PRIMARY MYELOFIBROSIS AND POST-POLYCYTHEMIA VERA / ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS PATIENTS Merih. Reis Aras
OP 05 INCIDENCE IN PH -NEGATIVE MYELOPROLIFERATIVE NEOPLASMS IN ARMENIA FROM 2005 TO 2019 Lusine Sahakyan
OP 14 COVID-19 INFECTION IN CANCER PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS WITH EMPHASIZING THE RISK AND PROGNOSIS STRATIFICATION Ghada Elgohary
OP 15 THE FACTORS THAT AFFECT THE RESULTS OF THE RESPONSE TO RITUXIMAB TREATMENT IN ITP PATIENTS Ahmet Kursad Güneş
19.35 - 20.45 E-POSTER PRESENTATIONS SESION IV - CHAIRS: Ilhami Kiki, Pinar Tarkun
PP 25 PROGNOSTIC VALUE OF PRE-TREATMENT NEUTROPHIL-LYMPHOCYTE AND PLATELET-LYMPHOCYTE RATIO IN DIFFUSE LARGE B-CELL LYMPHOMA: A SINGLE-CENTER EXPERIENCE Gizem Dağcı
PP 26 TWO DISEASES IN A SINGLE LYMPH NODE: NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA AND KAPOSI'S SARCOMA Esra Turan Erkek
PP 27 EXTRANODAL MARGINAL ZONE LYMPHOMA OF THE OCULAR ADNEXA Engin Kelkitli
PP 28 ALK (-) ANAPLASTİC LARGE CELL LYMPHOMA DİAGNOSED BY TONGUE ROOT BİOPSY:CASE REPORT Fatma Yılmaz
PP 29 POLATUZUMAB BASED CHEMOIMMUNOTHERAPY SHOWING COMPLETE RESPONSE IN A PATIENT OF R/R DIFFUSE LARGE B-CELL LYMPHOMA Ünal Ataş
PP 30 ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE VS CARFILZOMIB AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (IKEMA): INTERIM ANALYSIS OF A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY Mehmet Turgut
PP 31 RELAPSE OF MULTIPLE MYELOMA PRESENTING AS EXTRAMEDULLARY PLASMACYTOMA SURROUNDING THE AORTA: A RARE CASE REPORT Ömer Ekinci
PP 32 A RARE SUBTYPE OF POEMS SYNDROME: IGG4 SUBTYPE Fehmi Hindilerden
PP 33 MONOCLONAL GAMMOPATHY OF UNDERTEMINED SIGNIFICANCE AND SOLITARY PLASMACYTOMA: PROGRESSION FACTORS IN POPULATION OF GOMEL REGION IN BELARUS Zhanna Kozich
PP 34 POEMS SYNDROME: A "MULTIFACETED" ENTITY OF PLASMA CELL DISORDER Anna Sevoyan
PP 35 POMALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF HEAVILY PRETREATED MULTIPLE MYELOMA Claudio Cerchione
PP 36 CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA Claudio Cerchione

23 OCTOBER 2020

13.35 - 14.05 E-POSTER PRESENTATIONS SESSION V -Francesco Lo Coco Hall- Chairs: Sami Kartı, Fahri Şahin
PP 37 THE RELATIONSHIP OF HEPCIDIN, SOLUBLE TRANSFERRINE RECEPTOR, GROWTH DIFFERENTIATION FACTOR-15 AND ANEMIA IN MULTIPLE MYELOMA Birgül Öneç
PP 38 SERUM & SALIVARY FERRITIN LEVELS IN IRON DEFICIENCY ANEMIA IS THERE IS A DIFFERENCE? Amr Gawaly
PP 39 HEPCIDIN LEVEL CHANGES IN TYPE 2 DIABETES Amr Gawaly
PP 40 CHEMOTHERAPY DELIVERING PORT-A-CATH MIGRATION INTO THE HEART: A CASE REPORT Abdalraouf Omar
PP 41 REACTIVE LYMPHOCYTES IN BLOOD FILM OF A COVID-19 IRAQI PATIENT: A CASE REPORT Abdulsalam Al-Ani
PP 42 A STUDY OF HEMATOLOGICAL DISEASE PREVALENCE IN COVID-19 PANDEMIC: A SINGLE CENTER EXPERIENCE Vildan Gürsoy
20.30 - 21.00 ORAL PRESENTATION SESSION III - Elizer Rachmilewitz Hall - Chairs: Oral Nevruz, Huseyin Saffet Bekoz
OP 16 THE ROLE OF T HELPER 22 CELLS DURING ENGRAFTMENT AT HEMATOPOIETIC STEM CELL TRANSPLANTATION Orhan Kemal Yücel
OP 17 STORY OF SUCCESS OF HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION IN APLASTIC ANEMIA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICAL OUTCOME AND RISK ASSESSMENT. Ghada Elgohary
OP 28 THE PROGNOSTIC SIGNIFICANCE OF NEUTROPHIL/LYMPHOCYTE RATIO IN PATIENTS WITH TERMINAL CANCER Mustafa SerkanAlemdar
OP 29 ANTI-YO POSITIVE PARANEOPLASTIC CEREBELLAR DEGENERATION ASSOCIATED WITH OVARIAN CANCER: A RARE CASE REPORT Yusuf İlhan
OP 30 GASTROENTEROPANCREATIC NEUROENDOCRINE CARCINOMA ; SINGLE CENTER EXPERIENCE Orçun Can
19.45 - 21.20 E-POSTER PRESENTATIONS SESSION VI -Francesco Lo Coco Hall- Chairs: İsmet Aydoğdu, Demet Cekdemir
PP 43 A CASE OF MALIGNANT PERITONEAL MESOTHELIOMA AS A RARE CAUSE OF AUTOIMMUNE HAEMOLYTIC ANAEMIA Isabel Whybrow Huppatz
PP 44 ERDHEIM–CHESTER DISEASE: A SINGLE CENTER EXPERIENCE Esra Turan Erkek
PP 45 ACUTE BRUCELLOSIS PRESENTING AS LEUKOCYTOCLASTIC VASCULITIS Ömer Ekinci
PP 46 THE FREQUENCY OF ANEMIA IN THE ELDERLY PATIENT POPULATION IN VAN PROVINCE, TURKEY. A CROSS-SECTIONAL STUDY Ömer Ekinci
PP 47 EFFECT OF HELICOBACTER PYLORI INFECTION ON THE FIRST-LINE TREATMENT OUTCOMES IN PATIENTS WITH IMMUNE THROMBOCYTOPENIC PURPURA Ömer Ekinci
PP 48 SAFETY OF CAPLACIZUMAB IN PATIENTS WITHOUT DOCUMENTED SEVERE ADAMTS13 DEFICIENCY DURING THE HERCULES STUDY Sevgi Kalayoğlu Beşışık
PP 49 CAPLACIZUMAB INDUCES FAST AND DURABLE PLATELET COUNT RESPONSES WITH IMPROVED TIME TO COMPLETE REMISSION AND RECURRENCE-FREE SURVIVAL IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA Leylagül Kaynar
PP 50 TRANSPLANT IN APLASTIC ANEMIA USING COMBINED G-CSF PRIMED BLOOD AND BONE MARROW STEM CELLS – A RETROSPECTIVE ANALYSIS Ayesha Butt
PP 51 COMPARISON OF SINGLE AND DOUBLE AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA PATIENTS Ümit Yavuz Malkan
PP 52 ARE THE HEMOGLOBIN VALUES DIFFERENT AFTER SEX -MISMATCHED ALLOGENEIC STEM CELL TRANSPLANTATION? Şebnem İzmir Güner
PP 53 EXPERIENCE OF ISTANBUL FACULTY OF MEDICINE BONE MARROW BANK; PERIODICAL ACTIVITY DOCUMENTATION Fatma Oğuz
PP 54 THERAPEUTIC PLASMA EXCHANGE IN GASTRIC SIGNET RING CELL CARCINOMA PRESENTING AS MICROANGIOPATHIC HEMOLYTIC ANEMIA: A RARE CASE REPORT Ömer Ekinci

24 OCTOBER 2020

09.00 - 09.30 E-POSTER PRESENTATIONS SESSION VII -Francesco Lo Coco Hall- Chairs: Salih Aksu, Sinan Dal
PP 55 A SIGNET RING CELL CARCINOMA PRESENTED AS REFRACTORY ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA Ümit Yavuz Malkan
PP 77 CANDIDA GUILLERMONDII ONYCHOMYCOSIS INVOLVING FINGERNAILS IN A BREAST CANCER PATIENT UNDER DECETAXEL CHEMOTHRAPY Yassine Merad
PP 78 PRETREATMENT NEUTROPHILE LYMPHOCYTE RATIO (NLR) MAY HAVE A PROGNOSTIC ROLE IN PATIENTS RECEIVING PEMETREXED TREATMENT FOR ADVANCED STAGE NON SMALL CELL LUNG ADENOCARCINOMA Selçuk Seber
PP 79 SYSTEMIC INFLAMMATORY MARKERS AS PREDICTORS OF RESPONSE TO CHEMORADIOTHERAPY IN RECTAL CANCER Selçuk Seber
PP 56 HEALTH-RELATED QUALITY OF LIFE FOR CHILDREN WITH LEUKEMIA: CHILD AND PARENTAL PERCEPTIONS Ece Ocak
PP 57 RARE INFECTIOUS AGENTS IN CHILDREN WITH HEMATOLOGICAL DISEASE Yunus Akçabelen
PP 58 IDIOPATHIC HYPEREOSINOPHILIC SYNDROME ASSOCIATED PULMONARY HYPERTENSION IN A CHILD Yunus Akçabelen
13.15 - 13.45 E-POSTER PRESENTATIONS SESSION VIII -Francesco Lo Coco Hall- Chairs: Güven Çetin, Mehmet Ali Ucar 6 POSTERS
PP 59 A RARE VARIANT OF DYSKERATOSIS CONGENITA: RTEL1 DEFECT Çağrı Çoşkun
PP 60 ACQUIRED APLASTIC ANEMIA IN CHILDHOOD: SINGLE-CENTER EXPERIENCE Mustafa Bilici
PP 61 THE COURSE OF INTRACRANIAL BLEEDING IN THE PATIENT WITH IMMUNE THROMBOCYTOPENIA Mireldar Babayev
PP 62 THE CAUSE OF VERY SEVERE TROMBOCYTOSIS: IRON DEFICIENCY ANEMIA Veysiye Üzel
PP 63 IMMUNE MARKERS ARE CLOSELY RELATED TO THE REMISSION ACHIEVEMENT IN CHILDHOOD ACUTE MYELOID LEUKEMIA. Aleksandra Palladina
PP 64 THE COURSE OF TOXIC HEPATITIS AT THE STAGE OF TREATMENT CONSOLIDATION ACUTE LEUKEMIA IN CHILDREN Mireldar Babayev
18.15 - 18.45 ORAL PRESENTATION SESSION IV - Elizer Rachmilewitz Hall - Chairs: Vahap Okan , Ozgur Mehtap
OP 19 HEMATOLOGICAL PARAMETERS AND PERIPHERAL BLOOD MORPHOLOGIC ABNORMALITIES IN CHILDREN WITH COVID-19 Yunus Akçabelen
OP 20 RISK FACTORS AND OUTCOMES RELATED TO INTENSIVE CARE UNIT ADMISSION OF CHILDREN WITH HEMATOLOGICAL AND SOLID ORGAN MALIGNANCIES: SINGLE-CENTER EXPERIENCE Cigdem Kaya
OP 22 BONE MINERAL DENSITY AND BONE RESORPTION IN THE ACUTE LEUKEMIA DURING CHILDHOOD Saadet Akarsu
OP 23 A GIRL WITH SAMD9L MUTATION PRESENTING WITH PANCYTOPENIA, IMMUNODEFICIENCY AND MYELODSYPLASIA Dilek Gürlek Gökçebay
OP 24 THE EFFECTS OF VITAMIN D DEFICIENCY ON MYOCARDIAL DEFORMATION AND FUNCTIONS IN PATIENTS WITH Β-THALASSEMIA Ayça Koca Yozgat
OP 25 THE MOLECULAR SPECTRUM OF PATIENTS WITH HEREDITARY SPHEROCYTOSIS: A SINGLE CENTER EXPERIENCE Çağrı Çoşkun
18.15 - 19.55 E-POSTER PRESENTATIONS SESSION IX -Francesco Lo Coco Hall- Chairs: Güven Çetin, Mehmet Ali Ucar
PP 65 KLIPPEL-TRENAUNAY SYNDROME ASSOCIATED WITH CHRONIC MYELOID LEUKEMIA Çağrı Çoşkun
PP 66 MULTIPLE RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA WITH T(9;13) IN A CHILD Dilek Gürlek Gökçebay
PP 67 OCCURENCE OF ACUTE MYELOID LEUKEMIA AFTER PRIMARY HEPATIC CARCINOMA IN A PATIENT WHO HAD LIVER TRANSPLANTATION Çağrı Çoşkun
PP 68 ACUTE LYMPHOBLASTIC LEUKEMIA WITH EBV INFECTION AND MULTIPLE CHROMOSOMAL ABNORMALITIES IN A CHILD Dilek Kaçar
PP 69 HYPERCALCEMIA DUE TO CONCOMITANT USE OF ALL TRANS RETINOIC ACID AND VORICONAZOLE Ayça Koca Yozgat
PP 70 ACUTE LYMPHOBLASTIC LEUKEMIA IN THE CONTEXT OF CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME: A CASE REPORT Dilek Kaçar
PP 71 POTENTIAL RISK OF SUBCLINICAL IRON DEFICIENCY ANEMIA IN MISINTERPRETATION OF GLYCOSYLATED HEMOGLOBIN A1C (HBA1C): A CASE REPORT Salwa Bakr
PP 72 HEMATOLOGIC MANIFESTATIONS ASSOCIATED WITH DEFICIENCY OF ADENOSINE DEAMINASE 2 AND A NOVEL ADA2 VARIANT. Ehab Hanafy
PP 73 PYRUVATE KINASE DEFICIENCY MISDIAGNOSED AS CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE I Ayça Koca Yozgat
PP 74 HOW TO TREAT AND MANAGE COVID19 IN SCD PATIENTS Narmin Verdiyeva
PP 75 HIGH-DOSE METHYL PREDNISOLONE IN VENO-OCCLUSIVE DISEASE Arzu Akyay
PP 76 ISOLATED EXTRAMEDULLARY RELAPSE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION Zeliha Güzelküçük